Clinical trials recruiting for Left Atrial Appendage Closure
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Apixaban 2.5 mg BID | 1 |
| Single Antiplatelet Therapy or No Therapy (Control) | 1 |
| Standard-dose DOAC | 1 |
Self-screener
Recruiting trials
- Austrian Left Atrial Appendage Closure Registry
- CLOT-LESS - CLOsure Tailored: LEss Antithrombotic Strategy After LAAC for Stroke Prevention
- Non-antithrombotic Versus. Single Antiplatelet Therapy Following Left Atrial Appendage Closure
- OPTION-EMEA Clinical Trial
- WATCHMAN FLX Pro European Registry
Related conditions
Trials recruiting for Left Atrial Appendage Closure often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Left Atrial Appendage Closure trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.